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Introduction
Dividing cells undergo dramatic changes in shape during 
mitosis and cytokinesis (Glotzer, 2005; Barr and Gruneberg, 
2007). Adherent animal cells transition from a flattened “leaf-
like” morphology to a sphere, which then contracts at the 
equator to give rise to two new cells that readhere to the 
surrounding growth surfaces and adjacent cells. These pro-
cesses of cell adhesion and cytokinesis involve Rho family 
GTPase regulation of the actin cytoskeleton (Heasman and 
Ridley, 2008; Parsons et al., 2010). The GTPase RhoA is 
central to the process of cytokinesis in animal cells (Piekny 
et al., 2005). In anaphase, RhoA is activated at a tightly 
defined equatorial region of the cell cortex by the specific 
and conserved guanine nucleotide exchange factor (GEF) 
ECT2 (epithelial cell transforming 2; Tatsumoto et al., 1999; 
Kimura et al., 2000; Yüce et al., 2005). ECT2 targets to the 
midpoint of the dividing cells through interactions with the 
microtubule-bound centralspindlin complex and phospha-
tidylinositol phosphates in the inner leaflet of the plasma 
membrane (Su et al., 2011). Furthermore, a pool of Polo-like 
kinase 1 present on the central spindle locally activates 
ECT2 (Niiya et al., 2006; Petronczki et al., 2007; Wolfe 
et al., 2009). In this way, ECT2 drives the highly localized 
activation of RhoA and forms a signal for cytokinesis. Once 
activated, RhoA is then thought to recruit effector proteins, 
including the formin diaphanous and one or more members 
of the Rho kinase family (Castrillon and Wasserman, 1994; 
Madaule et al., 1998; Hickson et al., 2006; Bassi et al., 2011). 
Together, these effector proteins promote actin polymeriza-
tion and myosin-dependent cell contractility in this region, 
thereby giving rise to a cleavage furrow and contractile ring 
(Glotzer, 2005).
Several studies have shown that RhoA actively cycles 
between active and inactive forms during this process, sug-
gesting that a GTPase-activating protein (GAP) is needed in 
addition to the ECT2 GEF (Miller and Bement, 2009). The 
CYK4 subunit of the centralspindlin complex has a RhoGAP 
domain and has been viewed as the prime candidate for this 
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Western blotting confirmed the presence of both metaphase- 
and anaphase-specific phosphorylation events on both CYK4 
on threonine residues and MKlp1 at S911 (Fig. 1, C and D; 
Neef et al., 2006). The mobility of CYK4 was reduced in 
metaphase compared with anaphase samples, and this could be 
reversed by treatment with a phosphatase (Fig. S1, A–C). Like 
the purified CYK4 subunit alone, these complexes showed 
activity toward Rac1 and Cdc42 but not RhoA or Rab1 (Fig. 1 C). 
This activity was not altered when CYK4 centralspindlin com-
plexes were isolated from cells in which either Aurora B or Plk1 
was inhibited during anaphase using ZM447439 or BI2536, 
respectively (Fig. 1 D).
A previous study has reported that CYK4 is phosphory-
lated by Aurora B in the GAP domain at serine 387 adjacent to 
the arginine finger catalytic residue at position 385 (Minoshima 
et al., 2003). To investigate this, the relative phosphorylation 
of centralspindlin complexes in metaphase and anaphase was 
analyzed using stable isotope labeling and cell culture (SILAC) 
and mass spectrometry (MS; Fig. S1 D). Although this analy-
sis identified a series of metaphase- and anaphase-specific 
phosphorylations at candidate Cdk1, Aurora, and Polo kinase 
consensus motifs in the N- and C-terminal regions of CYK4, 
the putative regulatory phosphorylation at serine 387 was 
not identified (Fig. S1 D). In fact, no phosphorylation sites 
within the GAP domain were found. In contrast, the conserved 
Aurora B phosphorylation of MKlp1 at S911 was identified 
in anaphase samples by MS (Fig. S1 D) and Western blotting 
(Fig. 1 D), as expected (Neef et al., 2006). When recombinant 
CYK4 carrying S387A (nonphosphorylated) or S387D (phos-
phomimetic) mutations was compared with wild-type CYK4, 
the S387D mutant showed reduced Rac1 and Cdc42 GAP 
activity comparable with the R385A arginine finger catalytic 
site mutant (Fig. 2 A). However, no increase in activity toward 
RhoA was seen (Fig. 2 A). All of these mutant proteins can 
target to the central spindle region (Fig. 2 B) and interact with 
MKlp1 to form a centralspindlin complex (Fig. 2 C). Interest-
ingly, the S387D mutation showed only a small decrease in 
GAP activity when CYK4 was incorporated into MKlp1 cen-
tralspindlin complexes isolated from stable cell lines (Fig. 2 C). 
This may be caused by the stabilizing effect of MKlp1 binding 
to CYK4 (Mishima et al., 2002). In contrast, the R385A argi-
nine finger mutation still showed greatly reduced GAP activ-
ity toward Rac1 (Fig. 2 C).
Collectively, these data support the view that CYK4 is a 
Rac1 and Cdc42 GAP rather than a Rho GAP and that this 
activity is not modulated by phosphorylation. Although the 
CYK4 S387D mutant had reduced GAP activity, endogenous 
CYK4 GAP activity was constant through mitosis, despite 
changes in the phosphorylation state of the protein.
CYK4 GAP activity is required  
for cytokinesis
The role of the CYK4 GAP activity toward Rac1 and Cdc42 
was then tested using stable-inducible cell lines in which the 
endogenous copy of CYK4 can be replaced by a combination of 
siRNA to the CYK4 3-untranslated region (UTR) and induction 
of a transgene comprising a myc-tagged CYK4 open reading 
Rho GAP activity (Jantsch-Plunger et al., 2000; Mishima 
et al., 2002; Somers and Saint, 2003; Zavortink et al., 2005). 
However, biochemical analysis of CYK4 has found that it has 
little or no activity toward RhoA and has greater activity 
toward Rac1 (Touré et al., 1998; Jantsch-Plunger et al., 2000), 
and genetic evidence in Drosophila melanogaster indicates 
that the fly CYK4 inhibits Rac activity (D’Avino et al., 2004). 
This conundrum was apparently resolved when it was found 
that phosphorylation of CYK4 by Aurora kinases at the cen-
tral spindle in anaphase resulted in a switch in relative activity 
from Rac1 to RhoA (Minoshima et al., 2003). This simple pic-
ture is complicated by other studies that indicate that although 
CYK4 is an essential component of the centralspindlin com-
plex (Mishima et al., 2002), the GAP activity of CYK4 can be 
dispensed with under some conditions (Goldstein et al., 2005; 
Yamada et al., 2006). Most strikingly, chicken B cell lines en-
gineered to express a CYK4 GAP mutant grow and divide 
without obvious defect (Yamada et al., 2006). Furthermore, in 
Caenorhabditis elegans, mutations that reduce GAP activity, 
but have little effect on the localization or stability of CYK4, 
result in cytokinesis defects that can be suppressed by deple-
tion of Rac (Canman et al., 2008). Thus, CYK4 may directly 
limit Rac rather than RhoA activity during anaphase.
Here, we define the specific Rac1 and RhoA effector path-
ways operating during mitosis and investigate the function and 
regulation of CYK4 GAP activity in human cell lines. The 
results support the view that CYK4 is a crucial regulator of 
Rac1 in adherent cells and that inhibition of Rac1-dependent 
effector pathways in anaphase is needed for cytokinesis.
Results
CYK4 is a Rac1 and Cdc42 GAP
The CYK4 component of the centralspindlin complex has been 
reported to have both Rac1 and RhoA GAP activity (Jantsch-
Plunger et al., 2000) and to be regulated by phosphorylation 
during progression through mitosis and cytokinesis (Minoshima 
et al., 2003). To test the specificity of CYK4, recombinant 
CYK4 purified from bacteria was screened against a panel of 
Rho family GTPases. RalA, RalB, Rap1B, N-Ras, and Rab1 are 
Ras superfamily GTPases outwith the Rho family and acted as 
negative controls. GTP hydrolysis assays revealed that CYK4 
has GAP activity toward Rac1–3 and Cdc42 but not the other 
GTPases tested (Fig. 1 A). To eliminate the possibility that the 
RhoA preparations used were not competent for GTP hydroly-
sis, the broad specificity Rho family GAP ARHGAP1 was used 
(Rittinger et al., 1997a,b). ARHGAP1 was able to promote GTP 
hydrolysis by RhoA, Rac1, and Cdc42 but had no activity to-
ward the non-Rho GTPase Rab1 (Fig. 1 B). These results sug-
gest that CYK4 is not a RhoA GAP. However, in cells, CYK4 
is bound to the kinesin motor MKlp1 as part of the centralspin-
dlin complex and shows differential phosphorylation at differ-
ent stages of mitosis, and it was therefore possible this might 
alter the specificity of the GAP activity.
To test this, CYK4 centralspindlin complexes were iso-
lated from cells in G2 (interphase) or passing through mitosis 
(metaphase and anaphase). Analysis of these complexes using 
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Figure 1. Human CYK4 is a GAP for Rac and Cdc42 but not RhoA. (A) Recombinant human CYK4 was tested against a representative panel of Rho family 
GTPases, RalA, RalB, Rap1B, Ras, and Rab1. In brief, 100 pmol of each GTPase was incubated in the presence or absence of 0.5 pmol hexahistidine-
tagged CYK4 as described in the Materials and methods. The amount of CYK4-dependent GTP hydrolysis in picomoles per hour was calculated and 
plotted as a bar graph. (B) Recombinant human ARHGAP1 and CYK4 were tested against RhoA, Rac1, Cdc42, Rab1, or a GAP storage buffer blank. The 
amount of GAP-dependent GTP hydrolysis in picomoles per hour was calculated and plotted as a bar graph. (C) Endogenous MKlp1–CYK4 centralspindlin 
complexes were immune precipitated using MKlp1 antibodies from synchronized populations of HeLa cells in interphase, metaphase, or anaphase states. 
Control isolations were performed using GFP antibodies. These complexes were then used for GAP assays with RhoA, Rac1, Cdc42, and Rab1 as a nega-
tive control. The amount of centralspindlin-dependent GTP hydrolysis in picomoles per hour was calculated and plotted as a bar graph. Aliquots of the 
total cell lysate (input) and isolated complexes were Western blotted for MKlp1, CYK4, phosphothreonine Cdk1-phosphorylated CYK4 (pTP), and tubulin. 
(D) Endogenous MKlp1–CYK4 centralspindlin complexes were immune precipitated using MKlp1 antibodies from synchronized populations of HeLa cells 
in metaphase or anaphase cells treated with ZM447439 (Aurora B inhibitor) or BI2536 (Plk1 inhibitor). Control isolations were performed using GFP 
antibodies. These complexes were then used for GAP assays with RhoA, Rac1, Cdc42, and Rab1 as a negative control. The amount of centralspindlin-
dependent GTP hydrolysis in picomoles per hour was calculated and plotted as a bar graph. Aliquots of the total cell lysate (input) and isolated complexes 
were Western blotted for MKlp1, phosphoserine 911 Aurora-phosphorylated MKlp1 (pS911), CYK4, and tubulin. Error bars indicate the standard devia-
tions. IP, immunoprecipitation.
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Figure 2. Arginine finger mutations reduce CYK4 GAP activity to-
ward Rac1. (A) A schematic of CYK4 shows the conserved coiled 
coil, C1 putative membrane-binding region, and GAP domain with 
arginine finger residue at amino acid 385. Recombinant human 
ARHGAP1, CYK4, CYK4R385A, CYK4S387A, and CYK4S387D were 
tested against RhoA, Rac1, Cdc42, and Rab1. The amount of GAP-
dependent GTP hydrolysis in picomoles per hour was calculated 
and plotted as a bar graph. (B). HeLa cells were transfected with 
Myc-tagged CYK4, CYK4R385A, CYK4S387A, and CYK4S387D for 24 h, 
fixed, and then stained with antibodies to the Myc epitope, MKlp1, 
or tubulin. DNA was stained with DAPI. Bar, 10 µm. (C) HeLa cells 
stably expressing inducible Myc-tagged copies of CYK4, CYK4R385A, 
CYK4S387A, and CYK4S387D were treated for 36 h with an siRNA 
directed to the 3-UTR of CYK4 to deplete the endogenous protein 
or a control siRNA. At the same time, the cells were treated with 
doxycycline to induce the Myc-tagged transgenes. MKlp1–CYK4 
centralspindlin complexes were then immune precipitated using 
Myc antibodies. Control isolations were performed using GFP anti-
bodies. These complexes were then used for GAP assays with RhoA 
and Rac1. The amount of centralspindlin-dependent GTP hydrolysis 
in picomoles per hour was calculated and plotted as a bar graph. 
Aliquots of the total cell lysate (input) and isolated complexes were 
Western blotted for Myc, CYK4, MKlp1, and tubulin. Arrowheads 
indicate endogenous CYK4, and arrows show Myc-tagged CYK4. 
Error bars indicate the standard deviations. IP, immunoprecipita-
tion; WT, wild type.
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frame lacking the 3-UTR. Induction of wild-type CYK4 or the 
R385A GAP mutant in the presence of endogenous CYK4 had 
little effect on the outcome of cell division as measured by the 
number of binucleate cells (Fig. 3 A, siControl). Depletion of 
endogenous CYK4 without induction of the transgene resulted 
in a high frequency of binucleate cells (Fig. 3 A, siCYK4 3-UTR 
uninduced). Induction of the wild-type CYK4 transgene, but not 
the R385A GAP mutant, rescued this effect (Fig. 3 A, siCYK4 
3-UTR induced). CYK4 GAP activity is therefore required for 
efficient cytokinesis.
The GAP specificity data show that CYK4 can act on both 
Rac1 and Cdc42. It was therefore important to define which of 
these GTPases is expressed in the HeLa cells being used. First, 
antibodies to RhoA, Rac1, and Cdc42 were tested to show that 
they detect their target antigen equally well by Western blotting 
(Fig. S2 A). Western blot analysis of mitotic and asynchronous 
HeLa cell extract indicated that the cells express RhoA and 
Rac1 but little Cdc42 (Fig. S2 B). Furthermore, RhoA was the 
only one of these GTPases showing strong enrichment in the 
cleavage furrow region (Fig. S2, C–E). Because of these results, 
it was decided to focus on Rac1 as the most abundant target of 
CYK4 in HeLa cells.
The requirement for CYK4 GAP activity in cytokine-
sis is most simply explained if Rac1 has to hydrolyze GTP 
for this process to complete successfully. Experiments using 
cell lines expressing inducible copies of wild-type Rac1 or a 
hydrolysis-defective Rac1Q61L mutant support this idea. Induc-
tion of Rac1Q61L resulted in a time-dependent increase in binu-
cleate cells (Fig. 3 B), and RhoA, which is normally restricted 
to the furrow region in anaphase, failed to concentrate properly 
despite apparently normal recruitment of the centralspindlin 
complex (Fig. 3 C). An excess of activated Rac1 therefore in-
terferes with cytokinesis and normal cleavage furrow forma-
tion. Visual inspection of these cells revealed that the Rac1Q61L 
cells were highly flattened and spread when compared with the 
equivalent Rac1 wild type–expressing cells, suggesting that 
they are more adherent. This raises the obvious possibility that 
the normal function of CYK4 is to reduce Rac1-dependent sig-
naling in the cleavage furrow, which would otherwise interfere 
with cytokinesis. To address this possibility, the Rac1 effector 
pathway in mitosis and the role of CYK4 GAP activity were 
investigated in more detail.
Identification of RhoA and Rac1 effector 
pathways in mitotic cells
The different Rho family GTPases are known to couple to dis-
crete effector pathways and thereby give rise to different modes 
of actin dynamics important for cell contraction, cell adhesion, 
and cell motility (Heasman and Ridley, 2008; Parsons et al., 
2010). However, these studies have been mainly performed 
in interphase cells, and it is unclear whether mitosis-specific 
pathways exist. Pull-down experiments were therefore per-
formed using recombinant RhoA, Rac1, and Cdc42 to iden-
tify which effector pathways they couple with during mitosis. 
This approach revealed that RhoA, Rac1, and Cdc42 bound 
to specific groups of effector proteins (Fig. 4 A). The formin 
DIAPH1 (diaphanous 1) and the ROCK2 (Rho kinase 2) bound 
to RhoA, whereas the p21-activated kinases (PAKs) PAK1 and 
PAK2, the Rac1 and Cdc42 GEF ARHGEF7/-PIX (Manser 
et al., 1998), and the ARF6-GAPs (Vitale et al., 2000) GIT1 
and GIT2 bound to Rac1 (Fig. 4, A and B). This pattern of 
Rac effectors is consistent with a previous study showing that 
PAK, ARHGEF7, and the GIT proteins form a modular sig-
naling cassette essential for cell polarization and cell shape 
changes (Frank and Hansen, 2008). Some overlap between 
Rac1 and Cdc42 effectors was observed, but Cdc42 showed 
specific interactions with the Wiskott–Aldrich Syndrome 
protein (WASp)–interacting family, the inverse BAR (Bin/
Amphiphysin/Rvs) domain protein IRSp53, and specific formins 
(Fig. 4 A and Table S1). ARHGAP1 was present in RhoA 
and Rac1 pull-downs (Fig. 4, A and B), fitting with its com-
mon GAP activity toward RhoA, Rac1, and Cdc42 (Fig. 1 B). 
These effector pathways are consistent with the idea that Rho, 
Rac, and Cdc42 have discrete cellular functions in cell con-
traction and adhesion during mitosis (Fig. S3) and are simi-
lar to those reported previously in interphase cells (Frank and 
Hansen, 2008; Heasman and Ridley, 2008; Parsons et al., 
2010). Further experiments confirmed that RhoA and Rac1 
have the same pattern of effector binding in both interphase 
and mitotic cells (Fig. 4 C). Because Rac1 does not act via 
mitosis-specific effectors, but may undergo a mitosis-specific 
form of regulation, the relationship between CYK4 Rac GAP 
activity and these specific Rac1 effector pathways was there-
fore investigated.
CYK4 acts through Rac1-specific  
effector pathways
First, the effectors crucial for mediating the inhibitory ef-
fects of Rac1 on cytokinesis were defined. To do this, Rac1 
effectors were depleted using specific siRNA duplexes (Fig. S4) 
from cells expressing an inducible copy of Rac1Q61L. Induc-
tion of Rac1Q61L expression resulted in increased cell spread-
ing through mitosis, defective furrowing, and early cytokinesis 
failure in nearly 35–40% of cells (Fig. 5). Depletion of ECT2, 
the RhoA GEF required for furrow formation, RhoA itself, 
or the CYK4 component of centralspindlin required for cen-
tral spindle integrity increased this to nearly 65–75% cyto-
kinesis failure. In contrast, depletion of the Rac1 effectors 
ARHGEF7, PAK1, and PAK2 reduced cell spreading through 
mitosis and the extent of cytokinesis failure to 10% (Fig. 5). 
Furthermore, depletion of these effector proteins also rescue 
furrow formation (Fig. S5 A) defined by anillin, a marker for 
Rho-dependent organization of F-actin in the contractile ring 
(Gregory et al., 2008; Hickson and O’Farrell, 2008; Piekny 
and Glotzer, 2008; Kechad et al., 2012). No change was seen 
when ARHGAP1, GIT1, and GIT2 were depleted, showing 
that the inhibitory effect of activated Rac1 on cytokinesis did 
not require these proteins. Furthermore, depletion of Cdc42 
had little effect on cell spreading and did not increase or de-
crease the rate of cytokinesis failure.
The relationship between Rac1 effectors and CYK4 
GAP activity was then tested using stable-inducible cell lines 
in which the endogenous copy of CYK4 can be replaced by 
a combination of siRNA to the CYK4 3-UTR and induction 
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Figure 3. Rac1 inactivation by CYK4 is required for cytokinesis. (A) HeLa cells stably expressing inducible Myc-tagged copies of CYK4 or CYK4R385A were 
treated for 36 h with an siRNA directed to the 3-UTR of CYK4 to deplete the endogenous protein or a control siRNA. At the same time, the cells were 
treated with doxycycline to induce the Myc-tagged transgenes (induced) or left untreated (uninduced). The cells were fixed and then stained with antibodies 
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results seen with the Rac1Q61L cells, depletion of ARHGEF7, 
PAK1, and PAK2 reduced the extent of cytokinesis failure to 
10% (Fig. 6). Again, depletion of ARHGAP1, GIT1, GIT2, 
or Cdc42 had little effect on the rate of cytokinesis failure 
(Fig. 6). Importantly, depletion of Rac1 reduced the extent 
of a transgene comprising an EGFP-tagged CYK4 reading 
frame lacking the 3-UTR. Replacement of wild-type CYK4 
with the R385A GAP mutant resulted in 40% late stage cyto-
kinesis failure after furrowing (Fig. 6) and perturbed anillin 
staining in early anaphase cells (Fig. S5 B). Similar to the 
to tubulin, the Myc epitope, or DAPI to detect DNA. The number of binucleate cells was counted for each condition and plotted as a bar graph. Error bars 
show the standard deviation from the means (n = 3). Asterisks mark binucleate cells that have failed cytokinesis. (B) HeLa cells stably expressing inducible 
EGFP-tagged copies of Rac1 or activated Rac1Q61L were treated for the time indicated with doxycycline to induce the EGFP-tagged transgenes. The cells 
were fixed and then stained with antibodies to tubulin or DAPI to detect DNA. Rac1 was directly visualized by EGFP fluorescence. The number of binucle-
ate cells was counted for each condition and plotted as in the line graph. (C) Alternatively, the cells were fixed using TCA and stained for RhoA and with 
antibodies to EGFP to detect EGFP-Rac1. DAPI was used to detect DNA. siControl, nonsilencing control; WT, wild type. Bars, 10 µm.
 
Figure 4. RhoA and Rac1 couple to discrete effector pathways in mitotic cells. (A) Effector binding assays from mitotic HeLa cell lysate were performed 
using GST, RhoA, Rac1, and Cdc42 as described in the Materials and methods. Bound fractions were eluted using sample buffer and analyzed by SDS-
PAGE and MS. Coomassie brilliant blue–stained gels of the RhoA, Rac1, and Cdc42 complexes are shown. Proteins identified by MS are listed in the 
table and marked by the side of the appropriate gel. Peptide number and intensity give a measure of the relative abundance. (B) Western blot analysis of 
the input and bound effector proteins was performed using the antibodies shown in the figure. (C) Effector binding assays from interphase (Int) and mitotic 
(Mit) HeLa cell lysate were performed using GST, RhoA, and Rac1 as described in the Materials and methods. Samples of the input material and bound 
fractions were analyzed by Western blotting using the antibodies shown in the figure.
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and Rac1 that were enriched at the cell poles in cells express-
ing wild-type CYK4 (Fig. 7 B, CYK4 arrows) were spread 
evenly around the cell cortex when CYK4 GAP activity was 
compromised (Fig. 7 C, CYK4R385A). Examination of the side 
projection showed that cleavage furrow invagination was re-
duced in the CYK4R385A cells, and the midbody marked by 
CYK4 remained closer to the growth surface (Fig. 7 C), fitting 
with the idea that the cells are more adherent. The distribution 
of active Rac1 was then investigated using cells expressing a 
Cdc42 and Rac interactive binding (CRIB) domain reporter 
construct. Live-cell imaging revealed that in cells expressing 
the wild-type CYK4 GAP, active Rac1 accumulated at later 
time points at the spreading cell edges (Fig. 8 A and Video 1). 
This is consistent with previous work using fluorescence res-
onance energy transfer probes that also came to the conclu-
sion that Rac1 activity is focused at the cell poles and away 
from the cleavage furrow region when cells are exiting mitosis 
(Yoshizaki et al., 2003, 2004). In contrast, in cells express-
ing the CYK4 R385A GAP mutant, active Rac1 accumulated 
in the central furrow region at the bottom of the cell, where 
it touched the growth surface (Fig. 8, B and C; and Videos 2 
and 3). The CYK4 GAP mutant cells then underwent either an 
of cytokinesis failure, as expected if CYK4 acts via a Rac1-
dependent pathway (Fig. 6). The inhibitory effects of Rac1 
on cytokinesis in cells expressing the GAP mutant form of 
CYK4 or the activated Q61L mutant of Rac1 are therefore 
caused by specific effector pathways associated with cell 
spreading and adhesion.
Increased cell spreading in anaphase in the 
absence of CYK4 GAP activity
Careful inspection of CYK4 GAP mutant cells progressing 
through anaphase provided further support for the idea that 
altered cell spreading in the cleavage furrow region was per-
turbing RhoA function. These cells often displayed surface 
projections from the cleavage furrow region and reduced lev-
els of RhoA in the cleavage furrow (Fig. 7 A and Fig. S5B). 
Live-cell imaging of Rac1 confirmed that the CYK4R385A cells 
have a larger contact with the growth surface than the equiv-
alent CYK4 wild-type cells (Fig. 7, B and C, bottom). Mea-
surements on 20 cells showed a 2.5-fold increase in attached 
surface area at the start of anaphase from 108.3 ± 21.4 µm2 in 
cells expressing wild-type CYK4 to 269.7 ± 59.4 µm2 in the 
CYK4R385A GAP mutant cells. Furthermore, retraction fibers 
Figure 5. Depletion of Rac1 effectors rescues the cytokinesis defect of cells expressing a hydrolysis-defective Rac1 mutant. HeLa cells expressing inducible 
EGFP-Rac1Q61L were transfected with siRNA duplexes targeting CYK4, ECT2, Rac1-specific effectors, Cdc42, a nonsilencing control (siControl), or Myh9, 
which was a protein binding nonspecifically to Sepharose beads in Rho GTPase pull-downs. Rac1Q61L expression was induced for 48 h, and the cells 
were fixed and then stained with phalloidin to detect actin or DAPI to detect DNA. Rac1 was directly visualized by EGFP fluorescence. Binucleate cells 
are marked by asterisks. The number of binucleate cells was counted for each condition and plotted as in the bar graph. Error bars indicate the standard 
deviation from the means (n = 3). The dotted line indicates the extent of cytokinesis failure. Bars, 10 µm.
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the idea that the CYK4 GAP activity is required for the inhibi-
tion of Rac1 at cleavage furrow in anaphase (Fig. 10 A). In turn, 
this may reduce the activity of Rac1-dependent ARHGEF7 and 
PAK effector pathways associated with the regulation of cell 
spreading and adhesion (Fig. 10 B).
Discussion
Regulation of CYK4 activity  
by phosphorylation
Earlier work using the CYK4 GAP domain has suggested that 
CYK4 GAP activity is regulated by Aurora B phosphorylation 
(Minoshima et al., 2003), yet we find no evidence for this. Puri-
fied centralspindlin complexes containing full-length CYK4 
protein were purified in metaphase and anaphase phosphory-
lated forms but showed equivalent activity toward Rac1 and 
no detectable activity toward RhoA. Furthermore, phosphomi-
metic mutation of the putative Aurora phosphorylation site at 
serine 387 did not cause a switch in specificity from Rac1 to 
RhoA (Minoshima et al., 2003) but rather partial inactivation of 
Rac1 and Cdc42 GAP activity. This serine residue is conserved 
in other Rho family GAPs, including ARHGAP1, and the pub-
lished crystal structures show that it lies at the interface between 
the GAP and the substrate GTPase (Rittinger et al., 1997a,b). 
ARHGAP1 binds to RhoA without phosphorylation at this site, 
early (Fig. 8 B) or late stage failure in cytokinesis (Fig. 8 C). 
Although control cells have completed cytokinesis within 
171.1 ± 29.8 min, the CYK4R385A cells do not form an ex-
tended midbody and fail cytokinesis by 81.0 ± 21.8 min or 
form an extended midbody and fail cytokinesis after 293.1 ± 
53.6 min. Early failure was also associated with a near com-
plete loss of furrowing, large movements of the cell cortex, and 
oscillation of the active pool of Rac1 (Fig. 8 B and Video 2). 
This suggests that CYK4 is needed to inactivate Rac1 from 
early stages of anaphase, even if cytokinesis failure may only 
become apparent at later time points. These observations 
are consistent with the idea that activated Rac1 in the equa-
torial furrow region is inhibitory to proper cell furrowing 
and that this can ultimately result in abscission defects and 
cytokinesis failure.
The role of Rac1 effectors in the formation of adhesion 
complexes was then investigated under conditions in which the 
CYK4 GAP was active or inactivate. Vinculin, a component of 
focal adhesion plaques, was used as a marker of these struc-
tures. In control cells expressing wild-type active CYK4, vincu-
lin staining is diffuse in the cytoplasm during mitosis, consistent 
with a loss of adhesion, whereas CYK4 GAP mutant cells show 
defined punctate vinculin staining in the furrow region and at 
the cell cortex (Fig. 9). Depletion of PAK1 and ARHGEF7 
caused a loss of this defined vinculin staining in the CYK4 GAP 
mutant cell lines (Fig. 9). In summary, these findings support 
Figure 6. Depletion of Rac1 effectors rescues the cytokinesis defect of cells expressing the CYK4 arginine finger mutant. HeLa cells expressing inducible 
EGFP-CYK4 or GAP activity–defective CYK4R385A were transfected with control or CYK4 3-UTR siRNA duplexes in combination with siRNA duplexes target-
ing Rac1-specific effectors and Cdc42. CYK4 expression was induced for 60 h, and then, the cells were fixed and stained with antibodies to tubulin and 
DAPI to detect DNA. CYK4 was directly visualized by EGFP fluorescence. Binucleate cells are marked with asterisks. The number of binucleate cells was 
counted for each condition and plotted as in the bar graph. Error bars indicate the standard deviation from the means (n = 3). The dotted line indicates the 
extent of cytokinesis failure. siControl, nonsilencing control; WT, wild type. Bars, 10 µm.
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Figure 7. Cell surface projections emerge from the cleavage furrow in CYK4 GAP-defective cells. (A) HeLa cells expressing EGFP-Rac1 and inducible 
mCherry-CYK4 or GAP activity–defective CYK4R385A were transfected with control or CYK4 3-UTR siRNA duplexes. CYK4 expression was induced for 60 h, 
and then, the cells were TCA fixed and stained with antibodies to mCherry to detect CYK4, RhoA, or EGFP to detect Rac1. Arrows mark the cell surface 
projections seen emerging from the cleavage furrow region in CYK4R385A cells. (B and C) Alternatively, these CYK4 (B) or CYK4R385A (C) cells were used for 
time-lapse imaging. A bright-field (BF) image is shown at the time points indicated together with the bottom section where the cells touch the glass growth 
surface, a middle section through the cell equator, a maximum intensity projection along the z axis of all sections, or a side projection along the y axis. The 
dotted line indicates where abscission has occurred. The 4-min time point, bottom section, includes a quantitation of the area of the cell in contact with the 
surface (n = 20). Arrows mark Rac1 accumulation at the cell poles and associated retraction fibers. WT, wild type. Bars, 10 µm.
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Figure 8. Increased Rac1 activity in the cleavage furrow of CYK4 GAP-defective cells. (A–C) HeLa cells expressing EGFP-PAK1 CRIB domain and induc-
ible mCherry-CYK4 (A) or GAP activity–defective CYK4R385A (B and C) were transfected with CYK4 3-UTR siRNA duplexes and then used for time-lapse 
imaging. A bright-field (BF) image is shown at the time points indicated together with the bottom section where the cells touch the glass growth surface 
and a maximum intensity projection along the z axis of all sections. Timings are relative to the onset of anaphase. Cells expressing only GAP activity– 
defective CYK4R385A showed either early (B) or late (C) stage failure of cytokinesis, and examples of both outcomes are therefore shown. CYK4 wild-type 
cells underwent abscission after 171.1 ± 29.8 min, whereas CYK4R385A cells showed early failure after 81.0 ± 21.8 min or late failure after 293.1 ± 53.6 min 
(n = 29). Bars, 10 µm. (D) Rac1 activity at the cell equator (red) and cell poles (green) was determined by measuring the intensity of the PAK1 CRIB domain 
probe every minute as cells exited mitosis using the Volocity 5 volume and quantitation tools. This was performed on cells expressing wild-type and R385A 
GAP mutant CYK4. Mean values are plotted in the graphs, and error bars indicate the standard deviation from the means (n = 5). WT, wild type.
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so this is not an obligatory modification required for GAP activity, 
and there is no mechanism explaining why it would select for 
RhoA above Rac1.
Although phosphorylation at serine 387 was not detected 
and does not appear to be important for CYK4 activity in our 
hands, other phosphorylations were identified. These might be 
relevant for controlling CYK4 localization, which undergoes 
a switch from the cytosol in metaphase to the central spindle 
and equatorial cell cortex in anaphase. In this context, the 
Cdk1 consensus sites at T342 adjacent to the C1 domain and 
at T580 near to the C terminus may be significant. This might 
provide a way to control the access of CYK4 to its substrate 
GTPases at the cell cortex, and further studies will be required 
to address this issue.
CYK4 GAP activity and adherent  
cell divisions
Previous studies have painted a somewhat confused picture on 
the role of the CYK4 GAP activity in cytokinesis (Glotzer, 
2009). Chicken B cell lines expressing only a GAP mutant 
form of CYK4 are able to carry out the process of cytokinesis 
without any detectable defects (Yamada et al., 2006). Similarly, 
developing Drosophila neuroblasts do not appear to have cell 
division defects when CYK4 GAP activity is compromised 
(Goldstein et al., 2005). However, other studies indicate that 
CYK4 GAP activity is needed for assembly of a functional 
contractile ring and successful cell division in Drosophila 
(Somers and Saint, 2003; Zavortink et al., 2005) and Xenopus 
laevis oocytes (Miller and Bement, 2009). This has resulted in 
complex arguments postulating noncatalytic functions for the 
CYK4 GAP domain that in some way impact on RhoA func-
tion (Loria et al., 2012) and claims that phosphorylation can 
switch the specific activity of CYK4 from Rac1 to RhoA 
(Minoshima et al., 2003). We resolve some of these arguments 
by a careful analysis of CYK4 GAP activity in mitotic cells 
and by defining the specific effector pathways to which RhoA 
and Rac1 couple. Cells lacking CYK4 GAP activity are more 
adherent during anaphase, and this interferes with the formation 
of the cleavage furrow and hence cytokinesis. Depletion of 
Rac1 or Rac1 effectors involved in cell spreading and adhesion 
Figure 9. Visualization of adhesion complexes using vinculin staining in CYK4 GAP-defective cells in anaphase. HeLa cells expressing inducible EGFP-
CYK4 or GAP activity–defective CYK4R385A were transfected with control or CYK4 3-UTR siRNA duplexes in combination with siRNA duplexes targeting 
Rac1-specific effectors. CYK4 expression was induced for 60 h, and the cells were fixed and then stained with antibodies to GFP to detect CYK4 and 
vinculin and DAPI to detect DNA. Arrows indicate especially bright vinculin spots. The vinculin staining intensity was measured using ImageJ and is plotted 
in the bar graph. Error bars indicate the standard deviation from the means (n = 7). siControl, nonsilencing control; WT, wild type. Bars, 10 µm.
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Other data suggest that Cdc42 couples to the WASp pathway 
through WIPF1 and WIPF2 in these cells. However, because 
depletion of Cdc42 did not rescue the CYK4 GAP mutant pheno-
type, this pathway could not explain the division defect in these 
cells, so it was not investigated further.
Additional indirect support for the idea that CYK-4 is a 
Rac GAP comes from studies in C. elegans that showed CYK-4 
is important for polarization of the early embryo and the tar-
geting of the atypical protein kinase C and Par-3 complex 
(Portereiko et al., 2004; Jenkins et al., 2006). Because Par-3 has 
been directly linked to Rac and Cdc42 rather than Rho (Lin 
et al., 2000), these findings fit well with the idea that CYK4 is a 
Rac and Cdc42 GAP.
Collectively, these results obtained in highly different 
systems support the view that the crucial function of CYK4 
in cytokinesis is the inactivation of Rac and thereby ensuring 
the correct balance of Rac and Rho activity (Mandato et al., 
2000; Yoshizaki et al., 2004; D’Avino et al., 2005). In adherent 
rescues this defect. This provides a simple explanation for the 
observation that chicken B cells do not require CYK4 GAP 
activity to divide because they are grown in suspension and 
therefore nonadherent (Yamada et al., 2006). This may also be 
relevant in fly neuroblast divisions, in which the cells delami-
nate from the neuroectoderm as they undergo asymmetric cell 
divisions and therefore don’t display focal adhesions or junc-
tions to neighboring cells (Wodarz, 2005).
Our findings on adherent mammalian cell lines are 
broadly in agreement with those made in early embryonic de-
velopment in C. elegans in which it was also reported that 
depletion of Rac could suppress the phenotype of CYK-4 
E448K mutations (Canman et al., 2008). In that case, Rac 
function was linked to the Arp2/3 complex because depletion 
of WASp and WAVE could also recover the CYK-4 E448K 
mutant (Canman et al., 2008). In adherent human cells, we 
have identified a specific role for Rac1 and the PAK–ARHGEF7 
effector pathway required for cell spreading and adhesion. 
Figure 10. A model for CYK4 regulation of 
Rac1 activity in anaphase. (A) At the onset 
of anaphase, cells adhere at the cell poles 
and contract in the equatorial region, driven 
by Rac1 and RhoA, respectively. The RhoA 
exchange factor ECT2 is enriched at the 
cell equator because of interactions with the 
MKlp1–CYK4 centralspindlin complex. This 
leads to local activation of RhoA in the furrow 
region (shaded pale green). Rac1 is inacti-
vated in this region by the CYK4 GAP com-
ponent of centralspindlin, creating a zone of 
low Rac1 activity. This does not occur at the 
cell poles, so Rac1 activity is higher in these 
regions (shaded pale red). Central spindle 
microtubules are shown in pale blue. (B) Regu-
latory and effector pathways for RhoA and 
Rac1 are summarized, together with the events 
they are known to control. The identity of the 
mitotic RhoA GAP remains to be assigned. 
GIT1/2 have been previously assigned as 
ARF6 GAPs and are therefore shown as in-
hibitors of ARF6 function. ARF6 has a complex 
function in cytokinesis together with Rab35 
and modulates endocytic recycling (Chesneau 
et al., 2012).
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The cells were lysed in 1 ml cell lysis buffer (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, and 1% [vol/vol] Triton X-100 with protease and phos-
phatase inhibitor cocktails [Sigma-Aldrich]), left on ice for 20 min, and 
then centrifuged at 20,000 gav for 20 min at 4°C to remove insoluble 
debris. To isolate CYK4 complexes, 3 µg of sheep anti-MKlp1 or anti-
Myc protein G–Sepharose beads were added into 900 µl cell lysate and 
rotated at 4°C for 3 h. The beads were washed three times with cell lysis 
buffer and then used for GAP assays.
SILAC analysis of centralspindlin complexes
For SILAC experiments, DME formulated to lack l-arginine and l-lysine 
was used. Before use, l-arginine was added to a final concentration of 
84 mg/ml, and l-lysine was added to 146 mg/ml, with additional proline 
at 200 mg/ml to prevent metabolic conversion of arginine to proline. 
For “light,” Arg0Lys0 medium standard amino acids were used (Sigma-
Aldrich), and for “heavy,” Arg6Lys6 medium [13C6]-l-arginine-HCl and 
[13C6]-l-lysine-HCl were used (Cambridge Isotope Laboratories). Bovine 
serum (Invitrogen) was dialyzed overnight at 4°C against PBS using a 
10-kD molecular mass cutoff membrane to remove any amino acids. HeLa 
cells were grown for 3 wk in this medium to reach steady-state labeling 
with “light” and “heavy” amino acids. For the metaphase condition, 8 × 
15–cm confluent dishes of “light” cells were treated with 100 ng/ml no-
codazole for 16 h. Mitotic cells were harvested by shake off, washed 
three times with 37°C PBS, and then resuspended in warm growth me-
dium. The cells were incubated in a 5% CO2 incubator at 37°C for 20 min 
and then washed twice with ice-cold PBS. For the anaphase condition, 8 × 
15–cm confluent dishes of “heavy” cells were treated with 100 ng/ml 
nocodazole for 16 h, washed three times in 37°C PBS, and then replated 
in “heavy” growth medium and harvested when the peak of anaphase 
cells became visible under the microscope, typically after 45–60 min. 
Cells were harvested and washed in ice-cold PBS. Cell pellets were lysed 
by addition of 1.2 ml mitotic cell lysis buffer (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 40 mM -glycerophosphate, and 1% [vol/vol] IGEPAL 
with protease and phosphatase inhibitor cocktails [Sigma-Aldrich]). After 
15 min on ice, lysates were centrifuged at 20,000 gav for 20 min at 4°C 
to remove insoluble debris. Lysates were adjusted to 10 mg/ml, and then 
3 mg of each lysate was combined into a single tube together with 5 µg 
of sheep anti-GFP (control) or sheep anti-MKlp1 and 40 µl of packed pro-
tein G–Sepharose. After 4-h incubation at 4°C, immune complexes were 
recovered by centrifugation at 10,000 gav for 1 min and then washed 
once in lysis buffer and three times with 50 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, and 0.1% (vol/vol) IGEPAL. Samples were then resuspended in 
sample buffer and analyzed by MS.
MS
Protein samples for MS were separated on 4–12% gradient NuPAGE gels 
(Invitrogen) and then stained using a colloidal Coomassie blue stain. Gel 
lanes were typically cut into 12 slices and then digested with trypsin. The 
resulting tryptic peptide mixtures in 0.05% trifluoracetic acid were then 
analyzed by online liquid chromatography–MS/MS with a chromatogra-
phy column (nanoAcquity UPLC; Waters) and mass spectrometer (Orbitrap 
XL ETD; Thermo Fisher Scientific) fitted with a nanoelectrospray source 
(Proxeon). Peptides were loaded on to a 5-cm × 180-µm symmetry trap 
column (part no. 186003514; BEH-C18; Waters) in 0.1% formic acid 
at 15 µl/min and then resolved using a 25-cm × 75-µm column (part no. 
186003815; BEH-C18) in 99–37.5% acetonitrile in 0.1% formic acid at 
a flow rate of 400 nl/min. The mass spectrometer was set to acquire an 
MS survey scan in the Orbitrap (R = 30,000) and then perform MS/MS on 
the top five ions in the linear quadrupole ion trap after fragmentation using 
collision ionization (30 ms with 35% energy). A 90-s rolling exclusion list 
with n = 3 was used to prevent redundant analysis of the same ions. Max-
Quant and Mascot (Matrix Science) were then used to compile and search 
the raw data against the human International Protein Index database 
(Cox and Mann, 2008; Cox et al., 2009). Protein group and peptide lists 
were sorted and analyzed in Excel (Microsoft) and MaxQuant. MS and 
MS/MS spectra were manually inspected using Xcalibur Qual Browser 
(Thermo Fisher Scientific).
GAP assays
For GTP-loading reactions, 10 µl assay buffer, 73 µl H2O, 10 µl of 10-mM 
EDTA, pH 8.0, 5 µl of 1-mM GTP, 2 µl -[32P]GTP (10 mCi/ml; 5,000 
Ci/mmol; GE Healthcare), and 100 pmol Rho and other Ras superfam-
ily GTPases were mixed on ice. After 15 min of incubation at 30°C, 
loaded GTPases were stored on ice. GAP reactions were started by the 
addition of 0.5 pmol GAP or purified CYK4 centralspindlin complexes 
somatic cells, this may be most crucial for regulation of cell 
spreading adhesion, whereas in early embryonic divisions, it 
may be more important for the regulation of Rac and Cdc42 
during anteroposterior polarization events.
Materials and methods
Reagents and antibodies
Standard laboratory reagents were obtained from Thermo Fisher Scientific 
and Sigma-Aldrich. Antibodies to MKlp1 (1–444 aa), CYK4 (1–633 aa), 
and anillin (614–960 aa) were raised in sheep and rabbit using hexahisti-
dine-tagged human proteins expressed in and purified from bacteria. Spe-
cific antibodies were purified using the antigens conjugated to Affigel-15, 
eluted with 0.2 M glycine, pH 2.8, and then dialyzed against PBS before 
storage at 80°C. Rabbit antibodies to full-length recombinant PRC1 and 
an MKlp1 pS911 peptide, CRKRR(phospho-S)STVA, have been described 
previously (Neef et al., 2003, 2006, 2007). Commercially available anti-
bodies were used to ARHGAP1 (rabbit Cdc42 GAP; Bethyl Laboratories, 
Inc.), ARHGEF7 (rabbit Cool1/-Pix; Cell Signaling Technology), Cdc42 
(mouse; Cytoskeleton), Citron kinase (mouse Citron Rho-interacting kinase; 
BD), Cyclin B1 (mouse GNS3; EMD Millipore), DIAPH1 (rabbit; Bethyl 
Laboratories, Inc.), GIT1 (rabbit; Bethyl Laboratories, Inc.), GIT2 (rabbit; 
Bethyl Laboratories, Inc.), PAK1 (rabbit; Bethyl Laboratories, Inc.), PAK2 
(rabbit; Bethyl Laboratories, Inc.), pTP (mouse; Cell Signaling Technol-
ogy), Rac1 (mouse; Cytoskeleton), RhoA (mouse; Cytoskeleton), ROCK2 
(rabbit; Bethyl Laboratories, Inc.), tubulin (mouse DM1A [Sigma-Aldrich] 
or sheep [Cytoskeleton]), Vinculin (rabbit; Abcam), and WASF1 (rabbit; 
Sigma-Aldrich). Secondary antibodies, raised in donkey, to mouse, rabbit, 
and sheep/goat conjugated to HRP, Alexa Fluor 488, Alexa Fluor 555, 
Alexa Fluor 568, and Alexa Fluor 647 were obtained from Molecular 
Probes. Affinity-purified primary and secondary antibodies were used at 
1 µg/ml, and sera were used at a 1:1,000 dilution in PBS. A bench-
top microfuge (5417R; Eppendorf) was used for all centrifugations unless 
otherwise indicated.
Molecular biology and protein expression
Rho family GTPases were amplified from cDNA by PCR and cloned into a 
hexahistidine-GST tag bacterial expression vector pFAT2. The proteins 
were expressed in BL21(DE3) cells and purified using nickel–nitrilotriacetic 
acid agarose (Fuchs et al., 2007). ARHGAP1 and CYK4 were amplified 
from cDNA by PCR and cloned in the hexahistidine tag bacterial expres-
sion vector pQE32. CYK4 and ARHGAP1 were expressed in JM109 cells 
and purified using nickel–nitrilotriacetic acid agarose. For mammalian ex-
pression, inserts were amplified by PCR from cDNA and then cloned into 
the pcDNA4 and pcDNA5 vectors containing EGFP, mCherry, FLAG, or 
Myc tags. The siRNA duplexes used in this study are listed in Table S1.
Cell culture media preparation and cell culture conditions
HeLa were cultured in growth medium (DME containing 10% fetal bovine 
serum) at 37°C and 5% CO2. For plasmid transfection and siRNA transfec-
tion, TransIT LT1 (Mirus Bio LLC) and Oligofectamine (Invitrogen), respec-
tively, were used according to the manufacturers’ instructions. HeLa Flp-In 
cells (Invitrogen) expressing single copies of epitope-tagged transgenes 
were generated by transfecting pcDNA5-FLAG–, EGFP-, or mCherry vec-
tor–encoded transgenes and Flp-recombinase at a ratio of 1:9 into HeLa 
S3 Flp-In cells. Transfected cells were expanded onto 15-cm dishes 24 h 
after transfection, and stable clones were selected using 0.4 µg/ml blastici-
din and 100 µg/ml hygromycin. Single colonies were picked after a 14-d 
selection and amplified in 24-well plates, and expression was checked by 
Western blotting and microscopy.
Isolation of CYK4 and CYK4R385A centralspindlin complexes
Wild-type and catalytically inactive CYK4 complexes were isolated from 
3 × 15–cm dishes of Myc-CYK4 and Myc-CYK4R385A stable-inducible 
HeLa cell lines, or untransfected control cells were grown to 60% conflu-
ence. The cells were treated with CYK4 3-UTR siRNA to deplete the en-
dogenous CYK4 for 36 h. The cells were then arrested in mitosis with 
100 ng/ml nocodazole for 16 h. Mitotic cells were harvested by shake 
off, washed three times with warm PBS, and then resuspended in warm 
growth medium. The cells were incubated in a 5% CO2 incubator at 
37°C for 20 min and then washed twice with cold PBS. For the anaphase 
condition, cells were replated in growth medium and harvested when the 
peak of anaphase cells became visible under the microscope, typically 
after 45–60 min. Cells were harvested and washed in ice-cold PBS. 
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as specified in the figures. A 2.5-µl aliquot of the assay mix was scintil-
lation counted to measure the specific activity in counts per minute per 
picomoles of GTP. Reactions were then incubated at 30°C for 20 min and 
then split into two equal aliquots. Each aliquot was immediately added 
to 795 µl of ice-cold 5% (wt/vol) activated charcoal slurry in 50 mM 
NaH2PO4, left for 1 h on ice, and centrifuged at 16,100 gav to pellet the 
charcoal. A 400-µl aliquot of the supernatant was scintillation counted, 
and the amount of GTP hydrolyzed was calculated from the specific activ-
ity of the reaction mixture.
Rho family GTPase effector pull-downs
For binding assays, 25 µg GST-tagged Rho family GTPase was bound to 
10 µl of packed glutathione–Sepharose (GE Healthcare) in a 1-ml total 
volume of nucleotide loading buffer (NL100; 20 mM Hepes-NaOH, pH 7.5, 
100 mM NaOAc, 5 mM MgCl2, and 0.1% [vol/vol] Triton X-100) for 120 min 
at 4°C. The beads were first washed three times in 500 µl with NL100. 
1 ml of either 10 mg/ml interphase or mitotic cell extract was added to the 
beads together with 100 µl of 10-mM GTP. Binding was then allowed to 
proceed for 120 min at 4°C, rotating to mix. The beads were then washed 
three times with 1 ml NL100, and bound proteins were eluted by the 
addition of 30 µl of 3× loading buffer and incubated for 5 min at 
95°C. Eluted proteins were then analyzed on by SDS-PAGE and Western 
blotting or MS.
Microscopy and live-cell imaging
For PFA fixation, coverslips were washed twice with 2 ml PBS and fixed 
with 2 ml of 3% (wt/vol) PFA in PBS for 15 min. Coverslips were quenched 
with 2 ml of 50-mM NH4Cl in PBS and then incubated in a further 2 ml of 
quench solution for 10 min. Coverslips were washed three times in 2 ml 
PBS before permeabilization in 0.2% (vol/vol) Triton X-100 for 5 min. For 
TCA fixation, coverslips were washed twice with 2 ml PBS and fixed with 
2 ml of ice-cold 10% (wt/vol) TCA solution for 15 min. Coverslips were 
quenched three times with 2 ml of 30-mM glycine in PBS for 10 min each 
and then washed three times in 2 ml PBS. In all cases, primary and second-
ary antibody staining was performed in PBS for 60 min at room tempera-
ture. Affinity-purified antibodies were used at 1 µg/ml, whereas commercial 
antibodies were used as directed by the manufacturers.
Fixed samples on glass slides were imaged using a 60×, 1.35 NA 
oil immersion objective on an upright microscope system (BX61; Olympus) 
with filter sets for DAPI, EGFP/Alexa Fluor 488, Alexa Fluor 555, Alexa 
Fluor 568, and Alexa Fluor 647 (Chroma Technology Corp.), a camera 
(CoolSNAP HQ2; Roper Scientific), and imaging software (MetaMorph 
7.5; Molecular Devices). Illumination was provided by a 200-W metal 
halide light source (Lumen; Prior Scientific). For live-cell imaging, cells were 
plated in 2-cm dishes with a coverglass window in the bottom. Imaging 
was performed at 37°C in 5% CO2 using an inverted microscope (IX81; 
Olympus) with a 60×, 1.42 NA oil immersion objective coupled to a 
spinning-disk confocal system (UltraVIEW VoX; PerkinElmer) fitted with an 
EM charge-coupled device camera (C9100-13; Hamamatsu Photonics). 
Image stacks of 25–35 planes spaced 0.5–0.7 µm were taken at one to 
four stage positions every minute for 2–12 h. Exposure times were 10–33 
ms with an EM gain setting of 200 for EGFP- or mCherry-tagged proteins 
using 3% power on the 488- and 561-nm lasers, respectively. A bright-
field reference image stack was collected using 10-ms exposures. Maxi-
mum intensity projection images of the fluorescent channels without gamma 
adjustment were cropped in ImageJ (National Institutes of Health) and 
placed into Illustrator CS3 (Adobe) to produce the figures. Intensity mea-
surements were performed on the full 3D dataset using the volume quantita-
tion and object tracking tools of Volocity 5 (PerkinElmer).
Online supplemental material
Fig. S1 is a SILAC analysis of centralspindlin complex phosphorylation in 
metaphase and anaphase cells. The Rho GTPases expressed in HeLa cells 
were defined in Fig. S2, and a schematic of their effector pathways is 
shown in Fig. S3. Western blot controls for antibody specificity and siRNA 
efficiency for RhoA, Rac1, Cdc42, and their effector proteins are shown in 
Fig. S4. Staining for the cleavage furrow protein anillin in cells expressing 
hydrolysis-defective mutants of Rac1 is shown in Fig. S5. Table S1 contains 
a list of the siRNA duplexes directed toward cell cycle regulators, GTPases, 
and effector proteins investigated in the course of this study. Video 1 shows 
localization of activated Rac1 in anaphase cells expressing wild-type 
CYK4. Video 2 shows localization of activated Rac1 and early cytokinesis 
failure in cells expressing the GAP mutant CYK4. Video 3 shows localiza-
tion of activated Rac1 and late cytokinesis failure in cells expressing the 
GAP mutant CYK4. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201204107/DC1.
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